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Introduction   
Management guidelines were created to screen and manage asymptomatic renal stones in U.S. astronauts.  
The risks for renal stone formation in astronauts due to bone loss and hypercalcuria are unknown.  Astronauts 
have a stone risk which is about the same as commercial aviation pilots, which is about half that of the general 
population.  However, proper management of this condition is still crucial to mitigate health and mission risks in 
the spaceflight environment.   
 
Methods   
An extensive review of the literature and current aeromedical standards for the monitoring and management of 
renal stones was done.  The NASA Flight Medicine Clinic's electronic medical record and Longitudinal Survey 
of Astronaut Health were also reviewed.  Using this work, a screening and management algorithm was created 
that takes into consideration the unique operational environment of spaceflight. 
 
Results   
Renal stone screening and management guidelines for astronauts were created based on accepted standards 
of care, with consideration to the environment of spaceflight.  In the proposed algorithm, all astronauts will 
receive a yearly screening ultrasound for renal calcifications, or mineralized renal material (MRM).  Any areas 
of MRM, 3 mm or larger, are considered a positive finding.  Three millimeters approaches the detection limit of 
standard ultrasound, and several studies have shown that any stone that is 3 mm or less has a ~95% change 
spontaneous passage.  For mission-assigned astronauts, any positive ultrasound study is followed by low-dose 
renal computed tomography (CT) scan, and flexible ureteroscopy if CT is positive.  Other specific guidelines 
were also created. 
 
Discussion   
The term “MRM” is used to account for small areas of calcification that may be outside the renal collecting 
system, and allows objectivity without otherwise constraining the diagnostic and treatment process for 
potentially very small calcifications of uncertain significance.  However, a small asymptomatic MRM or stone 
within the renal collecting system may become symptomatic, and so affect launch and flight schedules, cause 
incapacitation during flight, and ultimately require medical evacuation.  For exploration class missions, 
evacuation is unlikely.  The new screening and management algorithm allow better management of mission 
risks, and will define the true incidence of renal stones in U.S. astronauts.  This information will be used to 
refine future screening, countermeasures and treatment methods; and will also inform the needed capabilities 
to be flown on exploration-class missions.  
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